» Articles » PMID: 37650627

Optimisation of TP53 Reporters by Systematic Dissection of Synthetic TP53 Response Elements

Overview
Specialty Biochemistry
Date 2023 Aug 31
PMID 37650627
Authors
Affiliations
Soon will be listed here.
Abstract

TP53 is a transcription factor that controls multiple cellular processes, including cell cycle arrest, DNA repair and apoptosis. The relation between TP53 binding site architecture and transcriptional output is still not fully understood. Here, we systematically examined in three different cell lines the effects of binding site affinity and copy number on TP53-dependent transcriptional output, and also probed the impact of spacer length and sequence between adjacent binding sites, and of core promoter identity. Paradoxically, we found that high-affinity TP53 binding sites are less potent than medium-affinity sites. TP53 achieves supra-additive transcriptional activation through optimally spaced adjacent binding sites, suggesting a cooperative mechanism. Optimally spaced adjacent binding sites have a ∼10-bp periodicity, suggesting a role for spatial orientation along the DNA double helix. We leveraged these insights to construct a log-linear model that explains activity from sequence features, and to identify new highly active and sensitive TP53 reporters.

Citing Articles

Optimized reporters for multiplexed detection of transcription factor activity.

Trauernicht M, Filipovska T, Rastogi C, van Steensel B Cell Syst. 2024; 15(12):1107-1122.e7.

PMID: 39644900 PMC: 11667439. DOI: 10.1016/j.cels.2024.11.003.


Crosstalk between paralogs and isoforms influences p63-dependent regulatory element activity.

Baniulyte G, McCann A, Woodstock D, Sammons M Nucleic Acids Res. 2024; 52(22):13812-13831.

PMID: 39565223 PMC: 11662943. DOI: 10.1093/nar/gkae1143.


Optimized reporters for multiplexed detection of transcription factor activity.

Trauernicht M, Filipovska T, Rastogi C, van Steensel B bioRxiv. 2024; .

PMID: 39091757 PMC: 11291157. DOI: 10.1101/2024.07.26.605239.


Determinants of p53 DNA binding, gene regulation, and cell fate decisions.

Fischer M, Sammons M Cell Death Differ. 2024; 31(7):836-843.

PMID: 38951700 PMC: 11239874. DOI: 10.1038/s41418-024-01326-1.

References
1.
Buschmann T, Bystrykh L . Levenshtein error-correcting barcodes for multiplexed DNA sequencing. BMC Bioinformatics. 2013; 14:272. PMC: 3853030. DOI: 10.1186/1471-2105-14-272. View

2.
Vassilev L, Vu B, Graves B, Carvajal D, Podlaski F, Filipovic Z . In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science. 2004; 303(5659):844-8. DOI: 10.1126/science.1092472. View

3.
Bourdon J, LELONG J, Dessen P, May P, Debuire B, May E . Further characterisation of the p53 responsive element--identification of new candidate genes for trans-activation by p53. Oncogene. 1997; 14(1):85-94. DOI: 10.1038/sj.onc.1200804. View

4.
Kheradpour P, Ernst J, Melnikov A, Rogov P, Wang L, Zhang X . Systematic dissection of regulatory motifs in 2000 predicted human enhancers using a massively parallel reporter assay. Genome Res. 2013; 23(5):800-11. PMC: 3638136. DOI: 10.1101/gr.144899.112. View

5.
Inga A, Storici F, Darden T, Resnick M . Differential transactivation by the p53 transcription factor is highly dependent on p53 level and promoter target sequence. Mol Cell Biol. 2002; 22(24):8612-25. PMC: 139870. DOI: 10.1128/MCB.22.24.8612-8625.2002. View